For optometrists & ophthalmologists

Justify Your Treatment Plan
in 30 Seconds

Enter age + axial length. In 30 seconds you have a risk score, a growth chart, and a parent-ready report — while the patient is still in the chair.

Start with a Sample Patient →

No sign up · No credit card · or enter your own patient data

📊 Based on published RCTs 🔒 No data transmitted (free) ⚡ <30 seconds per patient 9 treatment modalities
Live Preview
9
24.2
26mm Age 9 18
✓ Treatment saves 6.1mm by age 18 Live
See live stats ▼
91st
Percentile
31.4
mm at 18 (no Tx)
25.3
mm with Tx

↳ Open full app with patient tracking →

📈
Visualize progression
Project axial length growth curves to age 18 using peer-reviewed normative datasets, with 95% confidence intervals.
⚖️
Compare treatments
Evaluate MiSight®, Stellest®, Ortho-K, atropine, and 5 more modalities side-by-side with RCT-sourced efficacy data.
📄
Explain to patients & families
Instant PDF reports and a parent-friendly view that translates clinical projections into plain language — during the appointment.
How it works

From patient data to clinical insight in seconds

Designed around chairside workflow. No training required.

01
Enter patient data
Age, current axial length (OD/OS), and a prior measurement. Or skip prior data for a first-visit baseline estimate.
~10 seconds
02
See risk & projection
Growth rate, percentile rank, composite risk score, and projected axial length at age 18 — with and without treatment.
Instant
03
Generate & share
Print a branded PDF, share a family portal link, or run an AI summary for documentation — in one click.
~5 seconds
Clinical use

Built for real-world myopia management

Designed to support chairside decision-making without replacing clinical judgment. Outputs are clearly labelled as educational decision support.

Aligns with current myopia management guidelines
Efficacy values sourced directly from primary RCTs — Chamberlain 2019, Bao 2022, LAMP study, ATOM2, and more.
Suitable for patient and family discussion
A parent-facing view translates clinical numbers into plain-language outcomes. Turn the screen to parents and they understand immediately.
Deterministic scoring — no AI hallucination in core calculations
The projection engine is pure math. AI is used only for natural-language summaries, clearly labelled as structured clinical notes.
Multi-visit longitudinal tracking
Track progression across unlimited visits per patient. Growth rate, interval warnings, and treatment response update automatically.
Clinical evidence base

All projection values and treatment efficacy figures are sourced directly from peer-reviewed publications.

Tideman et al. 2018 — European growth curves (n=5,766). JAMA Ophthalmol
Sanz Diez et al. 2019 — Multi-ethnic normative datasets. Ophthalmic Physiol Opt
He et al. 2015 — Asian axial length growth curves. Ophthalmology
Chamberlain 2019 — MiSight® 55% AL reduction. Optom Vis Sci
Bao et al. 2022 — Stellest® 67% AL reduction. JAMA Ophthalmol
Yam et al. 2019 (LAMP) — Atropine dose-response. Ophthalmology
Chia et al. 2012 (ATOM2) — Atropine 0.01% long-term efficacy. Ophthalmology
Flitcroft 2012 — The complex interactions of retinal, optical and environmental factors in myopia aetiology. Prog Retin Eye Res
📤
Every report you share introduces MyopiaTracker to parents
Parents see the branded report and ask about it at their child's next appointment.
Generate a sample report →
See exactly what you get

Everything you need for the patient conversation

📊
Axial length projection chart — no-treatment vs selected treatment line, 95% CI bands, percentile curves, danger threshold reference.
⚖️
9-modality comparison table — all treatments ranked by projected AL at age 18 for this specific patient.
📄
Branded PDF report — clinic logo, visit history, charts, and AI clinical summary. One-click print or share via family portal QR code.
👪
Parent view — plain-language explanation of eye growth and treatment impact. No clinical jargon. Shareable as a QR link (Pro).
📄 Clinical Report · Sample Patient
Patient Summary
Age9.0 yrs
OD Current AL24.20 mm
Growth rate+0.80 mm/yr
AL percentile91st
Projection at Age 18
Without treatment31.4 mm ⚠
With Stellest®25.3 mm ✓
AL saved−6.1 mm
⚠ Growing 5.4× faster than same-age peers. Treatment review indicated.
✓ Clinical consideration: Stellest® or Combination Therapy for this growth profile.
Methodology

How the projections are calculated

Every number has a source. The projection engine uses peer-reviewed normative datasets and RCT-derived efficacy values — no black-box AI in the core calculation.

View projection formula +
Core projection formula
AL_projected = AL_current
  + growth_rate × years_to_18
  × (1 − tx_efficacy)

Where growth_rate = observed ΔAL / interval
tx_efficacy = RCT-derived reduction factor
Confidence interval: ±SD × √years

Composite risk score uses AL percentile (30%), growth velocity (28%), projected AL@18 (22%), parental myopia (12%), and near-work hours (8%). Weights derived from Tideman et al. 2018. The composite score is a clinical communication aid, not a validated diagnostic instrument.

Confidence intervals of ±5–10% apply. Individual outcomes vary. Population-average rates are applied; this tool does not account for individual biological variation.

Treatment efficacy
Combination Therapy (modeled)
68%
Stellest® (HALT)
67%
Atropine 0.05%
58%
MiSight® 1 day
55%
MiyoSmart® (DIMS)
52%
Ortho-K
50%
Atropine 0.025%
45%
Atropine 0.01%
30%
Outdoor/Behavioral
18%

Efficacy values represent change in axial elongation vs untreated control at ~2-year RCT endpoints — not final AL or cure rates. Treatment availability and regulatory approval vary by country; this site does not provide prescribing guidance. † Combination Therapy is a modeled composite (multiplicative formula, capped at 75% in-app); no single RCT validates this figure directly. ‡ The proximity of Combination (68%) and Stellest® monotherapy (67%) reflects the mathematical ceiling of stacking high-efficacy treatments — not a clinical equivalence finding. See Methodology for the full model.

Pricing

Free to start. Pro when you're ready.

Every clinician gets full projection and comparison tools for free, forever.

Free
$0/mo
Everything you need to get started.
Unlimited local patients
Full projection engine (9 modalities)
PDF reports
AI Insights (bring your own key)
Cloud sync
Family portal (secure link)
HIPAA BAA
Get started free →
Most popular
Pro
$49/mo
For growing practices ready for cloud sync.
⚠ HIPAA BAA not included — Enterprise required for U.S. HIPAA compliance
Everything in Free
Cloud sync across devices
Family portal & QR codes
AI Insights included
Tele-Monitor parent logging
Priority support
HIPAA BAA
Start 14-day trial →
Enterprise
$149/mo
For OD schools and multi-clinician groups.
Everything in Pro
Multi-clinician accounts
White-label branding
HIPAA BAA included
API access
Onboarding & training
Contact Sales →
Clinical resources

Evidence-based reference pages

Detailed clinical guidance on myopia management topics — each page cites primary literature and links directly to the tool.

Growth Charts
Axial Length Growth Chart Tool
Plot AL against Tideman 2018 normative curves and interpret percentile rankings.
Treatment Comparison
MiSight® vs Stellest® Efficacy
RCT-sourced comparison of the two leading optical myopia control modalities.
Practice Tools
Myopia Management Software Guide
What to look for in myopia management software for your optometry practice.
Pharmacology
Atropine 0.01% vs 0.025% vs 0.05%
LAMP study and ATOM2 dose-response data with prescribing guidance.
FAQ

Common questions

Questions? Email support@myopiatracker.com

Is this a regulated medical device?+

No. MyopiaTracker is a clinical decision support tool for visualization and patient education. It does not diagnose, prescribe, or replace clinical judgment. Not FDA-cleared as a medical device.

How accurate are the projections?+

Projections use published normative datasets (Tideman 2018, Sanz Diez 2019, He 2015) and RCT-derived treatment efficacy values. Confidence intervals of ±5–10% apply. Population-average rates; individual outcomes vary.

Do I need to create an account?+

No. The calculator is completely free with no login required. Data stays in your browser. Cloud sync and AI Insights are available on the Pro plan.

Is patient data HIPAA compliant?+

In free mode, all data stays in your browser — nothing is transmitted to our servers. Pro mode uses Google Firebase (BAA-covered Firestore). A HIPAA Business Associate Agreement is available on Enterprise plans only.

What treatment modalities are included?+

Nine modalities: MiSight® 1 day, Stellest® (HALT), Ortho-K, MiyoSmart® (DIMS), Atropine 0.01%, 0.025%, 0.05%, Combination Therapy, and Outdoor/Behavioural. All efficacy values from primary RCTs.

Can I use this on a tablet during consultations?+

Yes. The app is fully responsive and works on iPad and Android tablets. The free tier works completely offline — no internet required during consultations.

Ready to try it?

No signup. No card. Under 30 seconds to first result.

Start with a Sample Patient →

View pricing · Contact us